These activities have been supported by independent educational grants from AstraZeneca
Infectious Disease
A Call to Action
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
Eric Daar, MD; Lucy Horton, MD; Raymund Razonable, MD; Lewis Teperman, MD; Phyllis Tien, MD; Charles Vega, MD
Novel COVID-19 Subvariants and the Changing Treatment Landscape
A COVID-19 "Breaking News" Update
Eric S. Daar, MD
Updates to Preventing and Treating COVID-19 in Immunocompromised Patients
Effect of XBB.1.5, BQ.1, and BQ.1.1 Subvariants
Lewis W. Teperman, MD
Answers to Common Clinical Challenges in COVID-19
A COVID-19 "Breaking News" Update
Elizabeth P. Clayborne, MD, MA
Respiratory
Clinical Consults in COPD
Updates to Best Practice Recommendations
Beth Ammerman, DNP, FNP-BC; Charles P. Vega, MD, FAAFP; MeiLan K. Han, MD, MS; Ty J. Gluckman, MD, FACC
Hot Topics in Asthma
Increasing Control and Preventing Exacerbations
Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP
New Horizons in Severe Asthma
From the Airway Epithelium to Improved Patient Outcomes
Monica Kraft, MD; Erika Gonzalez, MD; Jonathan Corren, MD
Clinical Consults in Severe Asthma
New Approaches to Targeted Therapy
Flavia Hoyte, MD; Njira Lucia Lugogo, MD, MS; Neil Skolnik, MD
Reducing Risks in Asthma
Mucus Plugs and Airway Obstruction
Monica Kraft, MD; Steve N. Georas, MD
Answering the Call in Severe Asthma
Expanding Roles for Biologic Treatment Regimens
Monica Kraft, MD; Michael E. Wechsler, MD, MMSc; Jonathan Corren, MD; Njira Lucia Lugogo, MD, MS
